Shortcomings of the inflammatory bowel disease serology 7 panel

Pediatrics

Volumn 125, Issue 6, 2010, Pages 1230-1236

  Benor, Shira ^a   Russell, George H ^a   Silver, Michael ^a   Israel, Esther J ^a   Yuan, Qian ^a   Winter, Harland S ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

Anemia; Crohn disease; Erythrocyte sedimentation rate; Indeterminate colitis; Inflammatory bowel disease; Serological testing; Thrombocytosis; Ulcerative colitis

Indexed keywords

ATYPICAL PERINUCLEAR NEUTROPHIL CYTOPLASMIC ANTIBODY; BACTERIUM ANTIBODY; CBIR1 PROTEIN; CBRI1 FLAGELLIN ANTIBODY; FLAGELLIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN C ANTIBODY; PROTEIN ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD EXAMINATION; CHILD; COHORT ANALYSIS; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMMUNOASSAY; INDETERMINATE COLITIS; INTESTINE ENDOSCOPY; INTESTINE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATHOLOGY; PATIENT REFERRAL; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REPEAT PROCEDURE; RETROSPECTIVE STUDY; SCHOOL CHILD; SCREENING; SENSITIVITY AND SPECIFICITY; SEROLOGY; ULCERATIVE COLITIS;

ADOLESCENT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BLOOD SEDIMENTATION; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FLAGELLIN; GASTROESOPHAGEAL REFLUX; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; YOUNG ADULT;

EID: 77953080246     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-1936     Document Type: Article

References (29)

1. Mack DR, Langton C, Markowitz J, et al. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics. 2007;119(6):1113-1119
2. Beattie RM, Walker-Smith JA, Murch SH. Indications for investigation of chronic gastrointestinal symptoms. Arch Dis Child. 1995;73(4):354-355
3. Khan K, Schwarzenberg SJ, Sharp H, Greenwood D, Weisdorf-Schindele S. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis. 2002;8(5):325-329
4. Sabery N, Bass D. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia. Pediatrics. 2007;119(1). Available at: www.pediatrics.org/cgi/ content/full/119/1/e193
5. Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child. 2004;89(1):69-71
6. Canani RB, de Horatio LT, Terrin G, et al. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2006; 42(1):9-15
7. Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol. 2001;96(3):758-765 (Pubitemid 32240727)
8. Sandborn WJ, Loftus EV Jr, Colombel JF, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2001;7(3):192-201
9. Nakamura RM, Matsutani M, Barry M. Advances in clinical laboratory tests for inflammatory bowel disease. Clin Chim Acta. 2003;335(1-2):9-20 (Pubitemid 37338302)
10. Jaskowski TD, Litwin CM, Hill HR. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease. Clin Vaccine Immunol. 2006;13(6):655-660
11. Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem. 2006;52(2): 171-181 (Pubitemid 43185477)
12. Vermeire S, Joossens S, Peeters M, et al. Comparative study of ASCA (anti- Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology. 2001;120(4):827-833 (Pubitemid 32193179)
13. Gupta SK, Fitzgerald JF, Croffie JM, Pfefferkorn MD, Molleston JP, Corkins MR. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children. Inflamm Bowel Dis. 2004;10(3):240-244 (Pubitemid 38618253)
14. Mokrowiecka A, Gasiorowska A, Malecka- Panas E. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease. Hepatogastroenterology. 2007; 54(77):1443-1448 (Pubitemid 47203445)
15. Anand V, Russell AS, Tsuyuki R, Fedorak R. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can J Gastroenterol. 2008;22(1):33-36 (Pubitemid 351385649)
16. Elitsur Y, Lawrence Z, Tolaymat N. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience. J Clin Gastroenterol. 2005;39(8): 670-673 (Pubitemid 41177084)
17. Winter HS, Landers CJ, Winkelstein A, Vidrich A, Targan SR. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. J Pediatr. 1994;125(5):707-711 (Pubitemid 24350178)
18. Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004;99(11):2235-2241 (Pubitemid 39524716)
19. Papp M, Altorjay I, Norman GL, et al. Serore-activity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis. 2007;13(8): 984-992
20. Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007;44(5):653-674
21. Markowitz J, Kugathasan S, Dubinsky M, et al. Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology? Inflamm Bowel Dis. 2009;15(5):714-719
22. Romano C, Famiani A, Gallizzi R, Comito D, Ferrau' V, Rossi P. Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children. Pediatrics. 2008; 122(6). Available at: www.pediatrics.org/cgi/content/full/122/6/e1278
23. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005;128(7):2020-2028
24. Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002;122(5): 1242-1247
25. Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut. 1992;33(8): 1071-1075
26. Müller S, Styner M, Seibold-Schmid B, et al. Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis. World J Gastroenterol. 2005;11(44): 6988-6994 (Pubitemid 43126058)
27. Papadakis KA, Yang H, Ippoliti A, et al. Anti- flagellin (CBir1) phenotypic and genetic Crohn's disease associations. Inflamm Bowel Dis. 2007;13(5):524-530
28. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 1998;115(4):822-829 (Pubitemid 28452928)
29. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123(3):689-699